Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05904210 · ClinicalTrials.gov registry record
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®
A clinical trial, sponsored by Laboratoire français de Fractionnement et de Biotechnologies.
- Completed
- Registry status
- 17
- Enrollment target
NCT05904210 is a clinical trial that has completed, run by Laboratoire français de Fractionnement et de Biotechnologies. The registered enrollment target is 17 participants.
The verdict
NCT05904210 has completed, sponsored by Laboratoire français de Fractionnement et de Biotechnologies.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to assess the real-world utilization (effectiveness, safety, tolerability, and modalities of treatment) of SEVENFACT®.
Interventions
- DRUG SEVENFACT®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2024-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05904210
The ClinicalTrials.gov registry entry for NCT05904210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laboratoire français de Fractionnement et de Biotechnologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SEVENFACT® is the first listed.
NCT05904210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05904210 about?
NCT05904210 is a clinical study titled "Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®". Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® \[coagulation factor VIIa (recombinant)-jncw\] in the USA. The current study will provide a unique opportunity to describe the profile of the early patients selected for treatment with SEVENFACT® and to as...
What is the current status of trial NCT05904210?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2023-11-07. Estimated completion is 2024-05-09.
What interventions are being tested in trial NCT05904210?
The interventions under investigation include: SEVENFACT® (DRUG).
Who is sponsoring clinical trial NCT05904210?
This trial is sponsored by Laboratoire français de Fractionnement et de Biotechnologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.